Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Sub-Lingual_Tablet
gptkb:I_Wanna_Thank_Me |
| gptkbp:appointed_by |
gptkb:mountain
gptkb:skincare_product hospital settings injection home care settings |
| gptkbp:developed_by |
gptkb:1960
piperidine |
| gptkbp:has_ability |
morphine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fentanyl
|
| gptkbp:is_associated_with |
tolerance
withdrawal symptoms dependence overdose deaths illicit drug trade |
| gptkbp:is_available_in |
various formulations
tablet form lozenge form patch form injection form |
| gptkbp:is_available_on |
gptkb:fentanyl_buccal_tablet
gptkb:fentanyl_citrate gptkb:fentanyl_sublingual_spray gptkb:fentanyl_transdermal_system fentanyl nasal spray |
| gptkbp:is_considered |
highly potent
a dangerous drug when misused a major contributor to the opioid epidemic |
| gptkbp:is_often_associated_with |
cocaine
heroin |
| gptkbp:is_often_used_in |
severe pain
recreational drug use |
| gptkbp:is_related_to |
opioid crisis
|
| gptkbp:is_subject_to |
gptkb:municipality
abuse potential |
| gptkbp:is_used_for |
pain management
acute pain cancer pain postoperative pain |
| gptkbp:is_used_in |
gptkb:healthcare_organization
gptkb:hospital palliative care intensive care units emergency medicine chronic pain management anesthetic procedures pain relief protocols |
| gptkbp:lifespan |
3 to 12 hours
|
| gptkbp:metabolism |
liver
|
| gptkbp:produced_by |
pharmaceutical companies
|
| gptkbp:regulates |
many countries
|
| gptkbp:scientific_classification |
Schedule II controlled substance
|
| gptkbp:side_effect |
nausea
confusion constipation sedation respiratory depression |
| gptkbp:suitable_for |
opioid-naive patients
|